ORIOLA OYJ |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.982 EUR | +0.51% |
|
-4.81% | -9.01% |
| Apr. 25 | Transcript : Oriola Oyj, Q1 2024 Earnings Call, Apr 25, 2024 | |
| Apr. 25 | Oriola Oyj Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Presenter SpeechRobert Andersson (Executives)Okay. So welcome to Oriola quarter 4 and full yea...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Oriola Oyj, formerly known as Oriola-KD Corporation Oyj, is a Finland-based company active in the pharmaceutical sector. The Company is engaged in the retail and wholesale of pharmaceuticals, acting as a channel between pharmaceutical manufacturers and consumers, primarily in Finland and Sweden. The Company's reporting segments are Consumer, Services, and Healthcare. Through its own pharmacies, the Company provides consumers with not only medicines and pharmaceutical advice but also a selection of healthcare consumer products and customer service. The Company is active through a number of subsidiaries located throughout Europe, including PharmaService OY, Oriola AB, Oriola Oyj, Farenta Oy, Kronans Droghandel Apotek AB and Svensk dos AB.
Sector
Pharmaceuticals
Calendar
2024-07-18
- Q2 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
0.977
EUR
Average target price
1.175
EUR
Spread / Average Target
+20.27%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -9.01% | 196M | |
| +16.62% | 70.95B | |
| +2.99% | 25.25B | |
| +5.38% | 8.67B | |
| +6.46% | 8.16B | |
| -21.01% | 7.91B | |
| +0.79% | 4.51B | |
| +17.12% | 4.31B | |
| -0.14% | 4.07B | |
| -3.92% | 3.84B |
- Stock Market
- Equities
- OKDBV Stock
- News Oriola Oyj
- Transcript : Oriola Oyj, 2018 Earnings Call, Feb 22, 2019
